GRAND RAPIDS — A $40 million investment by a Japanese pharmaceutical company provides Tetra Discovery Partners Inc. a strategic partner and capital to test and commercialize a new drug compound that could treat Alzheimer’s disease and a form of autism.

Published in Health Care

If Mark Gurney can’t find the capital he needs in Michigan, his drug development firm is poised to look for it elsewhere.

Published in Health Care

Venture capital investors say work over more than a decade to spur greater innovation and build a better entrepreneurial climate in Michigan has provided them with better investment prospects.

Published in Finance
Sunday, 11 December 2016 16:46

MiBiz Growth Report: Dec. 12, 2016

Here is the MiBiz Growth Report for Dec. 12, 2016: 

• M&A: Blue Wolf Capital Partners LLC, a New York-based private equity firm, has acquired the North American operations of New Zealand-based Tenon Limited. The company will be based in Grand Rapids and operate under a new name, Novo Building Products LLC. Novo is a manufacturer and distributor of speciality building products. Terms of the deal were not disclosed.

Published in Breaking News

Tim Parker wasn’t actively looking for a new opportunity when he came across a LinkedIn posting that intrigued him.

Published in Finance

Drug developer Tetra Discovery Partners LLC said it’s closed on $5 million in new venture capital funding.

Published in Breaking News

At some point in the coming months, Mark Gurney and directors at Tetra Discovery Partners LLC will decide which road to travel into the future for their company.

Published in Health Care

Four of the top five investments by venture capital firms in the state went to West Michigan companies in the third quarter.

Published in Breaking News

An experimental drug under development by Tetra Discovery Partners LLC has the potential to treat traumatic brain injury, according to the results of a pre-clinical trial.

Published in Breaking News